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Natural killer T cells (NKT) are a unique T cell 
lineage with the capacity to regulate immune 
responses. NKT cells are multifunctional. They 
have been described as being important in a 
variety of immune responses, including the re-
sponse to tumors, infectious agents, the main-
tenance of self-tolerance, and the prevention of 
autoimmunity (1, 2). In contrast to conven-
tional T lymphocytes and other regulatory T 
cells, NKT cells do not recognize peptide anti-
gen presented by classical MHC-encoded class 
I or II molecules; instead, their TCR interacts 
with glycolipid antigen presented by the MHC 
class I–like molecule CD1d (3). These T lym-
phocytes are mainly CD4+CD8, but a subset 
can be CD4CD8. NKT cells branch away 
from T cell lineage at the double-positive (DP) 
CD4+CD8+ stage in the thymus (4).
Invariant  NKT  (iNKT)  cells  represent  a 
subclass of NKT cells. They derive from DP 
thymocytes that express a TCR with a CDR3 
region  formed  by  a  semiinvariant  rearrange-
ment of V14-J18. iNKT cells are positively 
selected upon recognition of CD1d expressed 
on DP thymocytes loaded with glycolipids (1). 
iNKT react to a glycosphingolipid -galacto-
sylceramide (GalCer) presented by CD1d (5). 
CD1d-GalCer tetramers, which uniformly 
stain all iNKT cells, have been used to char-
acterize some NKT cell developmental steps 
and precursors. As CD1d-GalCer tetramer+ 
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Invariant natural killer T (iNKT) cells constitute a distinct subset of T lymphocytes exhibit-
ing important immune-regulatory functions. Although various steps of their differentiation 
have been well characterized, the factors controlling their development remain poorly 
documented. Here, we show that TGF- controls the differentiation program of iNKT cells. 
We demonstrate that TGF- signaling carefully and specifically orchestrates several steps 
of iNKT cell development. In vivo, this multifaceted role of TGF- involves the concerted 
action of different pathways of TGF- signaling. Whereas the Tif-1 branch controls 
lineage expansion, the Smad4 branch maintains the maturation stage that is initially 
repressed by a Tif-1/Smad4-independent branch. Thus, these three different branches of 
TGF- signaling function in concert as complementary effectors, allowing TGF- to fine 
tune the iNKT cell differentiation program.
© 2009 Doisne et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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that Smad2 and Smad3 could have Smad4-independent bio-
logical functions. A role has recently been proposed for the 
transcriptional intermediary factor 1 (Tif-1) in the TGF- 
signaling pathway (17, 18). This ubiquitous protein (also 
known as TRIM33, RFG7, PTC7, and ectodermin) selec-
tively binds receptor-phosphorylated Smad2/Smad3 in com-
petition with Smad4. Although the Smad2–Tif-1 interaction 
has biological effects independent of the Smad3–Tif-1 com-
plex in vitro, the importance of the Tif-1 branch in TGF- 
signaling in vivo remains unknown.
TGF- signaling plays a crucial role on T cell biology 
because mice selectively deprived of TGF-RI or -RII on 
their T cells develop massive autoimmunity and die by 3 wk 
of age (15, 19). Thymic development of conventional CD4 
and CD8 T cells does not appear to be under TGF- control, 
but TGF- seems clearly involved in the peripheral differen-
tiation of selective T cell subsets such as Foxp3+ regulatory T 
cells and Th17 cells (15, 20, 21, 22). Interestingly, the com-
plete deprivation of TGF- signaling in / T lymphocytes, 
obtained by the crossing of a strain of floxed TGF-RII mice 
with CD4-Cre transgenic mice (CD4-Cre x TGF-RIIfl/fl), 
leads to a sharp defect in CD1d-GalCer tetramer+ NK.1.1+ 
cells in both the thymus and the spleen (14, 15). These obser-
vations suggest that TGF- could control the thymic devel-
opment of the iNKT cells. However, given that the ablation 
of TGF- signaling in T cells is associated with strong auto-
immune disorders, T cell activation and acute cytotoxicity 
(15), it has been difficult to decipher whether the defect of 
iNKT cells in CD4-Cre x TGF-RIIfl/fl mice is a direct effect 
of TGF- on iNKT cell precursors or the consequence of 
autoimmune disorders that affect the capacity of the thymus 
environment to differentiate iNKT cells. Whether TGF- con-
stitutes a specific factor directly controlling the thymic differ-
entiation of iNKT precursor thus remains totally unknown.
In this study, we demonstrate that TGF- signaling di-
rectly orchestrates several steps of iNKT precursor differenti-
ation, ascribing a crucial and specific role for this cytokine in 
iNKT thymic development. We provide evidence that three 
branches of TGF- signaling, Smad4, Tif-1, and the Tif-
1–Smad4-independent signaling pathway, function in con-
cert. Each of these TGF- signaling branches is selectively 
dedicated to the control of a specific differentiation step of 
iNKT cells, allowing TGF- to fine tune the iNKT cell dif-
ferentiation program.
RESULTS
TGF- signaling directly and specifically controls iNKT 
precursor differentiation
We have previously reported that thymic development of 
conventional CD4, CD8 T lymphocytes is not affected by 
TGF- signaling (14, 15, 21). In the thymus, iNKT cells 
branch away from the T cell lineage at the CD4+CD8+ (DP) 
stage and are positively selected upon recognition of CD1d ex-
pressed on DP cells that are themselves loaded with glycolipids. 
Thus, a putative effect of TGF- on the thymic development 
of iNKT cells could affect iNKT precursors alone, the capacity 
precursors progress to mature HSAlow cells, three differentiation 
stages have been reported. iNKT cells go from the CD44low 
NK1.1 stage, through the CD44high NK1.1 stage, and fi-
nally reach the CD44high NK1.1+ stage. This iNKT differen-
tiation sequence is accompanied by a massive cellular expansion 
occurring  between  the  CD44low  NK1.1  stage  and  the   
CD44high NK1.1 stage. A majority of CD44high NK1.1 cells 
emigrate to the peripheral tissues, where they cease to proliferate 
and rapidly express a mature phenotype, becoming CD44high 
NK1.1+ and producing both IL-4 and IFN- (6). iNKT   
cells represent 2.5% of splenic T lymphocytes and 30% of 
liver T cells (5). Interestingly, a fraction of the CD44high 
NK1.1 cells do not emigrate to the periphery, but instead 
proceed to their terminal maturation inside the thymus, where 
they acquire the NK1.1 marker and other NK-related markers 
that characterize the lineage (e.g., Ly49 and NKG2 family 
members). The CD44high NK.1.1+ population constitutes 
long-lived resident cells for several months (7). Although the 
importance of peripheral iNKT cells in the regulation of im-
mune system has been widely reported, the significance of the 
iNKT intrathymic long-lived residents remains unknown (5).
Although it is known that CD1d expression on DP thy-
mocytes is required for iNKT cell selection and lineage differ-
entiation  (6),  and  that  both  IL-15  and  CD122  (IL-15R) 
expression are involved in the transition between the CD44high 
NK1.1  and  CD44high  NK1.1+  stages,  factors  that  control 
iNKT cell differentiation are poorly documented (8, 9). Some 
studies have proposed a role for two cytokines, GM-CSF and 
lymphotoxin, in iNKT cell development (10, 11). However, a 
recent investigation has reported that GM-CSF does not affect 
iNKT cell numbers in the thymus or in the periphery, but 
rather regulates their ability to secrete cytokines (12). More-
over, a role for lymphotoxin has been ascribed in iNKT cell 
emigration from the thymus rather than in iNKT cell develop-
ment (13). Recently, it has been suggested, by us and others, 
that TGF- could influence iNKT differentiation (14, 15).
TGF- is a widely expressed cytokine involved in the 
control of proliferation and differentiation of numerous cell 
types both inside and outside the immune system. The three 
isoforms of TGF- (TGF-1, TGF-2, and TGF-3) signal 
through a common serine–threonine kinase receptor com-
plex composed of the TGF-RI and TGF-RII subunits. 
Binding of TGF- to its receptor leads to the activation of 
the intracellular kinase domain of TGF-RII, which in turn 
phosphorylates the kinase domain of the TGF-RI subunit. 
The latter then phosphorylates the receptor-associated Smads 
(R-Smads), Smad2 and/or Smad3, which bind the common 
Smad (C-Smad), Smad4. Complexes of Smad2–Smad4 and 
Smad3–Smad4 then migrate to the nucleus and regulate the 
transcription of various genes. Interestingly, Smad-indepen-
dent pathways, such as MEK/MAP kinase, have also been 
reported (16). For many years Smad4 had been considered to 
be an obligate partner for the R-Smads Smad2 and Smad3 
and the mediation of the TGF- response through the Smad 
branch. However, the differences in phenotype observed   
between R-Smad-null and Smad4-null organisms suggested JEM VOL. 206, June 8, 2009 
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BM were detectable (unpublished data). Thus, in the absence 
of TGF- control, DP thymocytes remain a suitable envi-
ronment for iNKT differentiation. In agreement with this, 
the expression of CD1d at the surface of DP thymocytes 
from CD4-Cre x TGF-RIIfl/fl mice was similar to that of 
DP cells from littermate controls (unpublished data) and co-
culture of V14 hybridoma cell lines with DP thymocytes 
from either CD4-Cre x TGF-RIIfl/fl mice or littermate con-
trols showed no significant difference in the capacity of DP to 
present GalCer antigen (Fig. 1 B).
Collectively,  this  first  set  of  experiments  reveals  that 
TGF- directly affects thymic iNKT precursor cells and not 
the thymic environment mandatory for their selection, sug-
gesting a specific role for TGF- in the thymus that is con-
fined to the control of iNKT precursor development.
TGF- signaling controls several steps of iNKT precursor 
differentiation
Thymic iNKT precursor differentiation goes through several 
established chronological steps defined by CD44 and NK1.1 
expression. To determine the effects of TGF- signaling on 
of DP to select iNKT precursors, or both. To test these three 
hypotheses, we have performed mixed BM transfers in re-
constituted, sublethally irradiated B cell– and T cell–deficient 
recipients (rag2ko). BM cells from CD1dko mice, which DP 
cells can lead to iNKT precursors but cannot positively select, 
were transferred into rag2ko recipients with congenic Ly9.1-
expressing BM cells from either CD4-Cre x TGF-RIIfl/fl 
mice or CD4-Cre x TGF-RIIwt littermate controls (Fig. 1 A). 
In CD4-Cre mice, the Cre transgene is expressed at the DP 
stage of thymocyte development. Consistent with this, DP 
thymocytes and their progeny from CD4-Cre x TGF-RIIfl/fl 
BM cells escape TGF- control. 6–7 wk after BM transfers, 
we analyzed the capacity of CD4-Cre x TGF-RIIfl/fl DP 
thymocytes  to  complement  the  deficiency  of  DP  from   
CD1dko BM to select iNKT cells. Strikingly, iNKT cells from 
CD1dKO donors were found in the spleens of all chimeric 
mice. However, iNKT cells from CD4-Cre x TGF-RIIfl/fl 
BM were barely detectable compared with iNKT cells from 
CD4-Cre x TGF-RIIwt BM (Fig. 1 A). In addition, from 
the  CD4-Cre  x  TGF-RIIfl/fl/CD4-Cre  x  TGF-RIIwt 
mixed BM transfer, only iNKT cells from wild-type mouse 
Figure 1.  Functional thymic environment to select iNKT cells in the absence of TGF- signaling. (A) Flow cytometric analysis of splenocytes in 
mixed BM chimeras. T cell–depleted BM from 2-wk-old CD4-Cre x TGF-RIIfl/fl mice or wild-type littermate mice were mixed with BM from CD1dKO mice 
(ratio 1:1) and transferred into rag2KO animals. 6–7 wk later, the presence in the spleen of iNKT cells was investigated using CD1d-GalCer tetramers and 
TCR- staining. The results are representative of three different experiments with three animals per group. (B) Proliferation analysis of CD1d-restricted 
V14-expressing DN32D3 hybridoma in the presence of thymocytes from either wild-type animals or CD4-Cre x TGF-RIIfl/fl mice and different concen-
tration of GalCer. Mean ± SD. n = 2, from two independent experiments.1368 TGF- AND iNKT | Doisne et al.JEM VOL. 206, June 8, 2009 
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Figure 2.  Control of iNKT cell precursor development by TGF- signaling. Flow cytometric analysis of the presence of iNKT cells in the thymus (A), 
liver (B), or spleen (C) of 14-d-old CD4-Cre x TGF-RIIfl/fl mice (TGF-RIIKO), CD4-Cre x Stopfl/fl TGF-RICA mice (TGF-RICA), or wild-type mice (TGF-RIIwt). 
Absolute numbers of CD1d-GalCer tetramer+ cells among either HSAlow cells or B220+ cells are illustrated by graphs and absolute numbers for each 
development stage are illustrated in supplemental table 1. CD44, NK1.1 staining on purified CD1d-GalCer tetramers thymocytes (A) and on CD1d-
GalCer tetramers+ B220 cells from either the liver (B) or spleen (C). IL-4, IFN-, staining on either NK1.1 or NK1.1+ CD1d-GalCer tetramer+ B220 
cells from spleen (C). The results are representative of three or four different experiments with three animals per group.
 
iNKT precursor differentiation, CD44 and NK1.1 stainings 
were performed on CD1d-GalCer tetramer+ thymocytes, 
purified either from CD4-Cre x TGF-RIIfl/fl mice or CD4-
Cre x Stopfl/fl TGF-RICA mice, the latter exhibiting a con-
stitutively active (CA) TGF- signaling in their T cells, and 
a normal thymic development of CD4 and CD8 conven-
tional T lymphocyte (21). Few CD1d-GalCer-tetramer+ 
thymocytes were observed in CD4-Cre x TGF-RIIfl/fl mice 
and their repartition among the different steps of differenti-
ation was greatly affected compared with those from litter-
mate controls (Fig. 2 A). Whereas in wild-type thymus, 
iNKT cell precursors were mainly NK1.1 at 2 wk of age, 
CD4-Cre x TGF-RIIfl/fl iNKT cell precursors from litter-
mate animals exhibited a repartition among the different steps 
of differentiation that was more similar to what is usually 
observed  in  adult  mice.  The  early  stages  of  development 
were rarely represented because the majority of the precur-
sors were NK1.1+ and also express NK markers such as 
NKG2D, NKG2A/C/E, and Ly49C/I (Fig. S1). In clear 
contrast with the aforementioned observations, our analy-
sis on CD1d-GalCer-tetramer+ thymocytes purified from 
CD4-Cre x Stopfl/fl TGF-RICA mice revealed an overrep-
resentation of the early differentiation stage CD44low NK1.1 
and a large deficiency in both CD44high NK1.1 precursors 
and the mature CD44high NK1.1+ cell subset (Fig. 2 A). To 
exclude the possibility that the rare iNKT cells observed in 
CD4-Cre x TGF-RIIfl/fl animals were caused by a poten-
tial defect of Cre-mediated recombination, CD4-Cre x 
TGF-RIIfl/fl mice were bred onto a Cre recombination re-
porter allele, i.e., YFP flanked by LoxP sites were knocked 
into the ROSA26 locus (Rosa26 YFPfl/fl). In these animals, 
all the CD1d-GalCer tetramer+ cells were both YFP+ and 
deficient for TGF-RII (unpublished data). In agreement 
with the lack of thymic iNKT cell precursors, few CD1d-
GalCer tetramer+ T cells were detectable in both the liver 
and spleen from CD4-Cre x TGF-RIIfl/fl mice compared 
the controls (Fig. 2 B and not depicted). Moreover, as in the 
thymus, the few iNKT cells observed at the periphery of 
CD4-Cre x TGF-RIIfl/fl mice were mostly NK1.1+ (Fig. 2, 
B and C), but produced both IFN- and IL-4, which is 
similar to iNKT cells from wild-type animals (Fig. 2 C), 
suggesting  that  these  cells  are  fully  functional.  In  clear 
contrast, the overexpression of TGF- signaling in T cells 
lead to an increase of peripheral CD1d-GalCer tetramers+ 
T cells, but these cells presented a defect of maturation with 
both a defective NK.1.1 expression and a weak IFN- pro-
duction compared with iNKT cells from wild-type animals 
(Fig. 2, B and C).
Overall, these results reveal that TGF- signaling controls 
several key steps of iNKT cell differentiation ranging from 
the early to late precursor differentiation stage. TGF- signal-
ing affects the maturation of both the thymic resident iNKT 
cells and iNKT precursors that have reached the periphery.
TGF- signaling controls apoptosis in early iNKT precursors
Because the iNKT differentiation step between the CD44low 
NK1.1 and the CD44high NK.1.1 stage is accompanied by 
a massive cellular expansion (6), it is possible that the defect of 
both CD44low NK1.1 and CD44high NK.1.1 cells observed 
in CD4-Cre x TGF-RIIfl/fl mice, results from an impair-
ment of their proliferation capacity. Surprisingly, Ki-67 stain-
ing of both CD44low NK1.1 and CD44high NK.1.1 cells 
from 14-d-old CD4-Cre x TGF-RIIfl/fl mice and CD4- 
Cre x Stopfl/fl TGF-RICA mice was similar to that observed 
for all differentiation stages in the littermate controls (Fig. S2). 
We thus postulated that TGF- could affect the survival of 
iNKT cell precursors. When CD1d-GalCer tetramer+ thy-
mocytes were stained with both anti–annexin V and 7-amino-
actinomycin-D (AAD), two to three times more apoptotic 
CD44low NK1.1 cells and CD44high NK.1.1 cells were   
observed in CD4-Cre x TGF-RIIfl/fl mice compared with 
the littermate controls, demonstrating an antiapoptotic effect of 
TGF- signaling on early iNKT precursors (Fig. 3 A). Be-
cause IL-7 has been established as a crucial cytokine for the 
survival of thymocytes, particularly for iNKT cells (23, 24), 
we asked whether TGF- could affect CD127 (IL-7-R) ex-
pression on early iNKT cell precursors (Fig. 3 B). Consistent 
with their apoptosis, CD44low NK1.1 and CD44high NK1.1 
cells from CD4-Cre x TGF-RIIfl/fl mice expressed lower 
levels of CD127. Interestingly, the overexpression of TGF- 
signaling (TGF-RICA) affects neither CD127 expression nor 
the survival capacity of iNKT precursors, suggesting that in 
wild-type animals, endogenous TGF- signaling levels appear 
to be sufficient to maintain early iNKT survival.
TGF- signaling is thus crucial to both maintain a high 
level of CD127 expression on early iNKT cell precursors and 
prevent the apoptotic death of these highly dividing cells.
TGF- signaling controls T-bet and CD122 (IL-15R)  
in iNKT precursors
The deprivation of TGF- signaling leads to a massive repre-
sentation  of  CD44high  NK1.1+  precursors  among  the  few 
CD1d-GalCer tetramers+ T cells. Moreover the overex-
pression of TGF- signaling is associated with a sharp reduc-
tion of this same late stage of iNKT differentiation (Fig. 2), 
suggesting that TGF- signaling represses the transition 1370 TGF- AND iNKT | Doisne et al.
Altogether, these results reveal that TGF- signaling di-
rectly or indirectly represses T-bet and CD122 expression in 
both CD44low NK1.1 and CD44high NK1.1 precursors, 
and prevents the latter from massively maturing.
The Smad4 branch of TGF- signaling controls iNKT cell 
late differentiation
TGF-R can signal through three different branches: the 
Smad4-dependent pathway, the Tif-1–dependent pathway, 
and the Tif-1/Smad4-independent pathway. The Smad4 
branch has been reported to act as a mediator for many TGF- 
effects in numerous cell types. Thus, we first investigated 
the role of Smad4 in iNKT cell differentiation. To do this, 
we used mice selectively deficient for Smad4 in their T cells 
from the DP stage. These animals were obtained by breeding 
of CD4-Cre transgenic animals with floxed smad4 mice, as 
previously described (27). Interestingly, the proportion of 
CD44low NK1.1 and CD44high NK1.1 precursors was sim-
ilar to that observed in control littermate mice (Fig. 5 A), 
excluding a role for the Smad4 branch in the survival main-
tenance  of  early  iNKT  precursors.  Moreover  mature   
CD44high NK1.1+ cells were not overrepresented in the absence 
of Smad4-dependent signaling, contrary to what was ob-
served when TGF- signaling was totally abrogated (Fig. 5 A). 
This, again, excludes a role for the Smad4 branch in the tran-
sition of CD44high NK1.1 cells to CD44high NK1.1+ cells. 
However, the CD44high NK1.1+ cells, express a lower level 
of NK.1.1 marker in the absence of Smad4-dependent sig-
naling (Fig. 5 A). Because NK1.1 expression has been shown 
to be dependent on CD122 and T-bet expression (25, 26), 
we next analyzed the expression of CD122 and T-bet. We 
between CD44high NK1.1 and CD44high NK1.1+ cells and 
that the few mature cells observed have escaped TGF- sig-
naling.  The  transition  between  CD44high  NK1.1  and   
CD44high NK1.1+ cells is known to be dependent on the cell 
surface expression of the IL-2/IL-15 receptor common  
subunit (CD122). Interestingly, although CD122 is not 
highly expressed on CD44high NK1.1 and CD44high NK1.1+ 
cells, its modest expression has been shown to play a key role 
on iNKT maturation (25). To further investigate the mecha-
nisms by which TGF- controls the progression of CD44high 
NK1.1 to CD44high NK1.1+ cells, we analyzed CD122 (IL-
15R) expression on CD1d-GalCer tetramer+ thymocytes. 
In agreement with the representation of the mature stage   
observed in Fig. 2, CD122 was expressed early on iNKT 
precursors escaping TGF- regulation as compared with cell 
controls (Fig. 4 A). In clear contrast, CD122 cell-surface ex-
pression was impaired on all precursors from CD4-Cre x 
Stopfl/fl TGF-RICA mice compared with precursors from 
their littermate controls (Fig. 4 B). Because the transcription 
factor T-bet has been shown to be a key factor for the matu-
ration of iNKT cell precursors and to control CD122 cell 
surface expression (26), we proceeded to investigate whether 
TGF- signaling modulates T-bet expression in iNKT cell 
precursors. The abrogation of TGF- signaling in CD4-Cre 
x TGF-RIIfl/fl mice lead to early expression of T-bet in 
precursors, whereas T-bet expression was highly repressed   
in the same iNKT precursors from CD4-Cre x Stopfl/fl  
TGF-RICA mice (Fig. 4, A and B). Interestingly, CD44high 
NK1.1+ cells from all three kinds of mice, even when rare, 
expressed similar levels of T-bet, suggesting that these cells 
are fully mature.
Figure 3.  Control iNKT cell precursor apoptosis by TGF- signaling. Flow cytometric analysis of CD1d-GalCer tetramer+ enriched from thymus 
from 14-d-old CD4-Cre x TGF-RIIfl/fl mice (TGF-RIIKO), CD4-Cre x Stopfl/fl TGF-RICA mice (TGF-RICA), or wild-type mice (TGF-RIIwt) and stained for 
either CD44, NK1.1, or annexin V and incubated with 7-AAD (A) or CD44, NK1.1, and CD127 (B). These results are representative of three different experi-
ments with two or three mice per group.JEM VOL. 206, June 8, 2009 
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Altogether, these results demonstrate that the Tif-1 branch 
of TGF- signaling is responsible for the survival maintenance 
of the early precursors of iNKT cells.
The Tif-1/Smad4-independent branch of TGF- signaling 
controls iNKT cell intermediate differentiation
Because we found that TGF- signaling represses both T-bet 
and CD122 expression in both CD44high NK1.1 and CD44high 
NK1.1+ precursors, and hence impairs their maturation in 
CD44high NK1.1+ cells, TGF- signaling in wild-type mice 
should be repressed, at least at the intermediate stage (CD44high 
NK1.1) of differentiation, to allow these precursors to pro-
ceed to maturity. The analysis of both tgf-rI and tgf-rII ex-
pression revealed a down-regulation of the expression of both 
TGF-R genes in CD44high NK1.1 precursors compared 
with early and late precursors (Fig. 7 A). This down-regulation 
was confirmed at the protein level by analysis of the surface 
expression of TGF-R (Fig. 7 B). In addition, this lack of 
TGF-R expression at the CD44high NK1.1 stage was associ-
ated with the repression of several genes known to be up-regu-
lated by TGF- signaling (Fig. 7 C), confirming an impairment 
of TGF- responsiveness in the CD44high NK1.1 precursors 
compared with the other differentiation stages.
Interestingly, neither the ablation of the Tif-1 branch nor 
the ablation of the Smad4 branch by itself can explain the over-
representation of mature CD44high NK1.1+ precursor cells ob-
served in the complete absence of TGF- signaling (CD4-Cre 
x TGF-RIIfl/fl mice; Fig. 2). We thus analyzed iNKT cell 
development in the absence of both the Tif-1 and Smad4 
branches, using CD4-Cre x Tif-1fl/fl x Smad4fl/fl animals.   
Interestingly, the deprivation of these two branches of TGF- 
signaling did not mimic the total ablation of the TGF- signal-
ing pathway (CD4-Cre x TGF-RIIfl/fl mice; Fig. 2), but led 
found that the low level of NK1.1 expression observed in 
CD4-Cre x Smad4fl/fl was associated with the impairment of 
both CD122 and T-bet expression, in CD44high NK1.1+ pre-
cursors (Fig. 5 B).
The Smad4 branch of TGF- signaling thus maintains both 
T-bet and CD122 expressions in mature iNKT precursors.
The Tif-1 branch of TGF- signaling controls early iNKT 
cell differentiation
Given that the role of the Smad4 branch appears to be restricted 
to the late maturation steps of iNKT precursors, we proceeded 
by investigating the contribution of another TGF- signaling 
pathway, the Tif-1 branch, in iNKT cell development. We 
generated mice selectively deficient for Tif-1 in their T cells, 
from the DP stage, by breeding CD4-Cre transgenic animals 
with floxed tif-1 mice (Fig. S3 A). The CD4-Cre x Tif-1fl/fl 
mice did not develop any sign of autoimmunity and inflamma-
tion (unpublished data). Moreover, in these animals, the con-
ventional CD4/CD8 T cell development in the thymus was 
similar that observed in wild-type animals (Fig. S3 B). How-
ever, as observed in CD4-Cre x TGF-RIIfl/fl animals, the de-
privation of the Tif-1–dependent signaling pathway led to a 
large decrease in the proportion of CD1d-GalCer–tetramer+ 
cells in the thymus. As in the absence of total TGF- signaling, 
the deprivation of the Tif-1 branch led to a large defect in 
CD44low NK1.1 precursors associated with their apoptosis and 
to a loss of CD127 surface expression (Fig. 6, A and B). How-
ever, contrary to what we observed in CD4-Cre x TGF-RIIfl/fl 
mice, no effect, either at the CD44high NK1.1+ precursor   
stage or on CD122 and T-bet expression, was observed in 
CD4-Cre x Tif-1fl/fl mice (unpublished data), excluding a po-
tential role for the Tif-1 branch in the transition of CD44high 
NK1.1 precursors to CD44high NK1.1+ precursors.
Figure 4.  Control of T-bet and CD122 expression by TGF- signaling. (A and B) Flow cytometric analysis of CD1d-GalCer tetramer+ cells en-
riched from thymocytes from either CD4-Cre x TGF-RIIfl/fl mice (TGF-RIIKO; A) or CD4-Cre x Stopfl/fl TGF-RICA mice (TGF-RICA; B) stained for CD44, 
NK1.1, T-bet, and CD122. These results are representative of four different experiments with two mice per group.1372 TGF- AND iNKT | Doisne et al.
resented, suggesting that the transition of CD44high NK1.1 
precursors to CD44high NK1.1+ precursors is repressed by the 
Tif-1/Smad4-independent branch of TGF- signaling, 
which is regulated by the level of expression of TGF-R.
DISCUSSION
iNKT  cells  constitute  a  unique  thymus-dependent  T  cell 
subset, characterized by the expression of a semiinvariant 
(V14-J18  in  mice  and  V24-J18  in  human)  TCR- 
to the addition of the phenotypes observed when the Tif-1 
and Smad4 branches were switched off separately (Fig. 7 D). 
We observed a large defect of CD44low NK1.1 precursors as-
sociated with their apoptosis, as in the absence of the Tif-1 
signaling pathway, and a low expression of NK1.1 on CD44high 
NK1.1+ cells associated with the impairment of both CD122 
and T-bet expression in CD44high NK1.1+ as reported in   
the absence of the Smad4 signaling pathway (Fig. 7 D and   
not depicted). CD44high NK1.1+ precursors were not overrep-
Figure 5.  Role of Smad4 signaling in iNKT cell differentiation. (A) Flow cytometric analysis of the presence of iNKT cells in the thymuses from either  
16-d-old CD4-Cre x Smad4 mice (Smad4KO) or wild-type mice and staining for CD44 and NK1.1 on CD1d-GalCer tetramer+ cells from the same thymuses. Abso-
lute numbers of CD1d-GalCer tetramer+ cells among either HSAlow cells are illustrated by graphs and absolute numbers for each development stage are illus-
trated in Table S1. (B) Flow cytometric analysis on CD1d-GalCer tetramer+ cells enriched from thymuses from either CD4-Cre x Smad4fl/fl mice (Smad4KO) or 
wild-type mice littermate stained for CD44, NK1.1, T-bet, and CD122. These results are representative of three different experiments with two mice per group.JEM VOL. 206, June 8, 2009 
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various pathological processes (28), it is critical to define the 
factors that govern their development. Our findings reveal 
TGF- to be a key factor for thymic iNKT cell develop-
ment. Although thymic precursors of both iNKT cells and 
conventional T cells require interaction with their respective 
self-ligands in the thymus environment for positive selection, 
the HSAlow iNKT cell precursors subsequently undergo a 
chain and markers traditionally associated with the NK cell 
lineage. iNKT cells are developmentally and functionally dis-
tinct from the mainstream CD4 and CD8 T cells. iNKT cells 
have been associated with a broad array of disorders, ranging 
from transplant rejection to tumors, various forms of autoim-
munity, atherosclerosis, allergy, and infection (5). Because of 
the importance of iNKT cells in immune regulation during 
Figure 6.  Role of Tif-1 signaling in iNKT cell differentiation. (A) Flow cytometric analysis of the presence of iNKT cells in thymuses from either 
16 d-old CD4-Cre x Tif-1fl/fl mice (Tif-1KO) or wild-type mice and staining for CD44 and NK1.1 on CD1d-GalCer tetramer+ cells from the same thy-
muses. Absolute numbers of CD1d-GalCer tetramer+ cells among either HSAlow cells are illustrated by graphs and absolute numbers for each develop-
ment stage are illustrated in supplemental table 1. B) Flow cytometric analysis on CD1d-GalCer tetramer+ cells enriched from thymuses from either 
CD4-Cre x Tif-1fl/fl mice (Tif-1KO) or wild-type littermate mice and stained for CD44, NK1.1, Annexin V, 7-AAD, and CD127. Mean fluorescence intensity 
is reported on the CD127 histograms. These results are representative of three different experiments with two mice per group.1374 TGF- AND iNKT | Doisne et al.
Figure 7.  Role of Tif-1/Smad4-independent signaling in the control of iNKT maturation. (A) tgf-b receptor expression analysis by RT-PCR per-
formed on purified CD1d-GalCer thymocytes from 16-d-old C57BL/6 mice. Relative gene expression are normalized on both hprt and g3pdh expression. 
(B) Flow cytometric analysis of CD1d-GalCer tetramer+ cells from iNKT cell-enriched thymocytes of C57BL/6 mice, stained for TGF-RII. Means of fluo-
rescence intensity (MFI) are reported with their SD. (C) jun-b, p21, pme-pai expression analysis by RT-PCR performed on purified CD1d-GalCer thymo-
cytes from C57BL/6 mice. Relative gene expression was normalized on actin expression. The results are representative of three different experiments 
from five to eight mice. (D) Flow cytometric analysis of the presence of iNKT cells in thymuses from either 13–14-d-old CD4-Cre x Tif-1fl/fl x Smad4fl/fl 
mice or wild-type littermate mice and staining for CD44 and NK1.1 on CD1d-GalCer tetramer+ cells from the same thymuses. Absolute numbers of 
CD1d-GalCer tetramer+ cells among HSAlow cells are illustrated by graphs, and absolute numbers for each development stage are illustrated in Table S1. 
The results are representative of three different experiments with at least three mice per group.JEM VOL. 206, June 8, 2009 
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dependent on the expression of T-bet, a transcription fac-
tor originally implicated in the Th1 cell lineage commitment 
(26). T-bet has been shown to induce CD122 in iNKT cell 
precursors (32). We have demonstrated a role for TGF- in 
the repression of both T-bet and CD122 expression in iNKT 
cell precursors. Interestingly, the ectopic expression of T-bet 
in immature iNKT cell precursors has been shown to be suf-
ficient  to  induce  their  full  maturation  and  function  (32). 
Given the central role of T-bet in iNKT cell maturation, by 
controlling the expression of T-bet in iNKT cells, TGF- is 
a key regulator for iNKT cell maturation. The absence of 
overrepresentation of CD44high NK1.1+ mature stage in both 
single- and double-knockout mice for Tif-1 and Smad4 re-
vealed that a Tif-1/Smad4-independent branch of TGF- 
signaling represses iNKT precursor maturation. Interestingly, 
in wild-type mice, TGF- signaling in CD44high NK1.1 
precursors is impaired, leading to iNKT precursor matura-
tion. Several arguments suggest the MEK/MAPK branch as a 
putative candidate of the Tif1-/Smad4-independent path-
way to explain how TGF- represses both T-bet and iNKT 
precursor maturation. TGF- has been proposed to repress 
T-bet during Th1/Th2 lineage commitment in vitro. Recent 
studies have demonstrated that this repression is under the 
MEK signaling pathway (33). Moreover, in wild-type ani-
mals, we found that the down-regulation of TGF- signaling 
at the CD44high NK1.1 stage was associated with the repres-
sion of mek1, whereas the expression of other actors of the 
MAPK, such as p38 and Erk, remained constant during iNKT 
cell differentiation (Fig. S4). Additional experiments should 
be carried out to confirm the role of MEK in iNKT cell dif-
ferentiation. By repressing the maturation of both highly di-
viding  CD44low  NK1.1  and  CD44high  NK1.1  cells,  the 
Tif-1/Smad4-independent pathway allows precursors to stay 
longer in highly divided stages, and thus could also contribute 
to promote iNKT lineage expansion along with the Tif-1 
branch. Interestingly, the TGF- signaling effects on the con-
trol of iNKT maturation are not restricted to the thymus be-
cause iNKT peripheral maturation was similarly affected. The 
large defect of mature NK1.1+ cells at the periphery in CD4-
Cre x Stopfl/fl TGF-RICA mice is also associated with their 
incapacity to produce IFN-, underlining the role of TGF- 
in the repression of iNKT cell maturation. Moreover, the rare 
but fully mature, peripheral iNKT cells generated in the ab-
sence of TGF- control produce both IL-4 and IFN-, which 
is similar to iNKT cells from wild-type mice, suggesting that 
TGF- is not mandatory for iNKT cell function.
Maturing CD44high NK1.1+ precursors express high lev-
els of TGF-R at their cell surface, and their responsiveness 
to TGF- is highly increased. This reactivation of TGF- 
signaling in CD44high NK1.1+ precursors is not associated 
with a repression of T-bet expression. This apparent discrep-
ancy can be explained by the relay role of the Smad4 branch 
of TGF- signaling. The Smad4 branch is responsible for the 
maintenance of both T-bet and CD122 expression in the 
CD44high NK1.1+ precursors, and allows them to mature and 
acquire a high level of NK1.1. Our data suggest that once 
complex series of activation and differentiation events. We 
have clearly demonstrated that TGF- directly orchestrates 
the sequence of thymic events that iNKT precursors un-
dergo. This sequence includes a lineage expansion, acquisi-
tion of the CD44high phenotype before either their migration 
to the periphery or their long stay in the thymus, and their 
maturation  to  CD44high  NK1.1+  (25,  29).  Unlike  IL-15, 
whose action is restricted to the maturation step, we revealed 
that TGF- controls several key steps of iNKT cell differen-
tiation, ascribing a crucial role for this cytokine iNKT cell 
development. Moreover, although iNKT cells and conven-
tional / T cells are derived from a common lineage at 
the DP stage, neither the ablation nor the overexpression of 
TGF- signaling in DP cells affects the thymic development 
of conventional / T cells (15, 21). Thus, TGF- appears 
as a key factor whose action in the thymus is confined to the 
control of several steps of iNKT cell differentiation.
iNKT cell lineage expansion has been regarded as the 
consequence of multiple rounds of cell division occurring be-
tween the CD44low NK1.1 and CD44high NK1.1 stages 
(5). Our results suggest that when they escape from TGF- 
control, the CD44low NK1.1 and CD44high NK1.1 precur-
sors keep dividing, but a large proportion of them undergo 
apoptosis, which dramatically reduces the pool of cells for the 
next iNKT differentiation steps, and thus reduces the total 
number of iNKT cells. Our observations strongly indicate 
that the iNKT lineage expansion is not only restricted to pre-
cursor cell proliferation, but also results from the survival 
maintenance of these dividing precursors by TGF-. This 
TGF- antiapoptotic effect is correlated with the mainte-
nance of IL-7R (CD127) expression at the cell surface of 
iNKT precursors, suggesting a role for the IL-7/IL-7R sig-
naling pathway in early iNKT precursors’ survival. In agree-
ment with this, a large decrease in iNKT precursors has been 
reported  in  IL-7KO  mice  (24).  Furthermore,  our  findings 
demonstrate that both the survival of iNKT early precursors 
and the maintenance of CD127 expression are under the 
control of the Tif-1 branch of TGF- signaling. However, 
whether Tif-1 directly controls CD127 expression remains 
to be investigated. Tif-1 is a ubiquitous nuclear protein that 
has been recently shown to be involved in hematopoietic cell 
fate via the TGF- pathway in vitro (17). Interestingly, in 
zebrafish, a mutation in mon, which is a gene identified as be-
ing an orthologous gene of tif-1 in mammals, leads to mas-
sive apoptosis of hematopoietic cells (30). Moreover, that TGF- 
has largely been reported to play an antiapoptotic role (31) 
supports our results, suggesting that the Tif1- branch could 
be a key signaling pathway for the TGF- antiapoptotic effect. 
In addition to the control of apoptosis, Tif-1 could regulate 
CD44 expression, and thus control the progression from 
CD44low to CD44high precursors.
After the expansion phase, precursors that become CD44high 
NK1.1 can either stay in the thymus or colonize peripheral 
organs and undergo a maturation phase accompanied by   
the cell-surface expression of both CD122 (IL-15R chain) 
and NK1.1. This maturation step has been reported to be 1376 TGF- AND iNKT | Doisne et al.
early stage, the Tif-1/Smad4-independent branch represses 
precursor maturation and allows iNKT lineage expansion in 
concert with Tif-1 branch. Next, the TGF- responsiveness 
is impaired, allowing precursor maturation. Finally, maturing 
precursors restore their capacity to fully respond to TGF- 
and the Smad4 branch assures the continuation of the matura-
tion program by maintaining high level of both T-bet and 
CD122 (Fig. 8). The action of each branch is conditioned by 
the action of the others. These sequential roles of the TGF- 
signaling branches during iNKT cell development ascribe a 
crucial role for TGF- in the iNKT cell differentiation.
MATERIALS And METHOdS
Mice. CD4-Cre x TGF-RIIfl/fl, and CD4-Cre x Smad4fl/fl mice were gen-
erated as previously described (15). Stopfl/fl TGF-RICA transgenic animals 
have been generated by insertion at the HPRT locus of the Lox-Stop-Lox 
cassette positioned upstream of the TGF-RICA-HA fusion gene (21). Tif1-
fl/fl mice harboring floxed exon 2–4 were generated by K.-P. Yan. The se-
lective deletion of the Tif1- in Tif1- cells is illustrated in Fig. S3. R26RYFP 
(Rosa26-YFPfl/fl) mice were provided by Frank Constantini (Columbia Uni-
versity, New York, NY) and CD1dKO mice by Luc Van Kaer (Vanderbilt 
University,  Nashville,  TN).  Beside  the  Stopfl/fl  TGF-RICA  mice  which 
were backcrossed 6 times in C57BL/6, each mouse stain was backcrossed   
8–10 times in a C57BL/6 (B6) background, and only littermates were used as 
controls. C57BL/6 mice were purchased from Charles Rivers Laboratories. 
Mice were maintained in a specific pathogen–free animal facility at the Pla-
teau de Biologie Expérimentale de la Souris (Lyon, France) and handled in 
the accordance with the institutional guidelines, and the protocols were ap-
proved by Comité Régional d’Ethique pour l’Expérimentation Animale.
Radiation BM chimeras. Radiation BM chimeras were generated upon 
transfer of 2–3 × 106 T cell–depleted BM cells into lethally irradiated Rag2KO 
recipients, as previously described (15).
Lymphocyte isolation. Cell suspensions were prepared from the thymus, 
spleen, and liver. Red cells in spleen were lysed with 168 mM NH4Cl and 
liver  lymphocytes  were  separated  by  gradient  density  using  Percoll  (GE 
Healthcare), as previously described (15).
precursors  have  turned  on  their  maturation  program,  the 
Smad4 branch thwarts the TGF- inhibitory effect on matu-
ration  driven  by  the  Tif-1/Smad4-independent  branch. 
Thus, TGF- has a double-edged sword effect on iNKT 
cell differentiation, through the Tif-1/Smad4-independent 
branch, which represses their maturation, and through the 
Smad4 branch, which continues the maturation process. In 
CD4-Cre x TGF-RIIfl/fl mice, all TGF- signaling branches 
are turned off, thus the maturation is not repressed by Tif-1/
Smad4-independent  branch,  and  the  iNKT  cell  precursor 
matures fully.
Therefore, the multifaceted role of TGF- during iNKT 
cell differentiation can be explained not only by the concerted 
action of different signaling branches, such as the Tif-1 branch 
and the Tif-1/Smad4-independent branch, but also by the 
interaction, or competition, between branches, such as the 
Smad4 branch and the Tif-1/Smad4-independent branch. 
Interestingly, the analysis of TGF- branches during the dif-
ferentiation of several cell types has also suggested an interac-
tion between the TGF- signaling pathways. In numerous 
cancers, at the early stage of tumor development, TGF- re-
presses tumor-growth, whereas at later stages TGF- facilitates 
tumor progression. The activation of the Tif-1/Smad4-inde-
pendent branch (MAPK) by TGF- has been proposed to 
facilitate tumor progression by TGF-. The loss of tumor 
growth inhibition by TGF- and the acquisition of oncogenic 
capacity correlates with the loss of the Smad4 branch function 
(34). Competition between the Smad4 branch and the Tif-1 
branch has also been suggested. During the blastula stage of 
Xenopus, a role for Tif-1 in the targeting of Smad4 for ubiq-
uitination and degradation has been reported, suggesting a po-
tential regulation of the Smad4 branch by Tif-1 protein (18). 
However, the interactions between TGF- signaling branches 
appear to be specific for a given cell type, because during hu-
man hematopoiesis, although two distinct roles have been as-
cribed to the Tif-1 branch and the Smad4 branch, no variation 
in Smad4 protein levels have been reported after overexpres-
sion or deletion of Tif-1 in human hematopoietic cells (17). 
In iNKT cell differentiation, the expression levels of both Tif-
1 and Smad4 stay constant over the different stages of iNKT 
cell development (unpublished data) suggesting that the Tif-1 
branch and the Smad4 branch do not interfere with one an-
other, but work in concert during a cellular differentiation 
program, each branch dedicated to a specific task.
In sum, our results propose that TGF- is a key regulator 
of iNKT cell differentiation. We have revealed that through 
different branches of its signaling pathway, TGF- can fine 
tune the complex iNKT cell differentiation cell program. 
These different signaling pathways function as complemen-
tary effector arms that, in association with a modulation of 
TGF- responsiveness between the differentiation stages, can 
explain the multiple roles of TGF- during iNKT cell devel-
opment.  TGF-  assures  lineage  expansion  via  the  Tif-1 
branch and maturation acquisition via the Tif-1/Smad4- 
independent branch, whereas the maintenance of the matura-
tion process involves the Smad4-dependent pathway. At an 
Figure 8.  Schematic model summarizing the effects of the three 
branches of TGF- signaling on iNKT cell differentiation. The Tif-1–
dependent branch prevents the apoptosis and allows lineage expansion. 
The Tif-1/Smad4-independent branch prevents maturation, and thus al-
lows lineage expansion. The Smad4-dependent branch allows maturation.JEM VOL. 206, June 8, 2009 
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